DDIT3 and diffuse large B-cell lymphoma: Double expressor DLBCL which are responsible for ~50% of R/R DLBCL cases, have an intermediate response (~50%) to R-CHOP, whereas double/triple hit lymphomas have an extremely poor response [19,20,22,23,28].